Birling M C, Hérault Y, Pavlovic G
CNRS, INSERM, CELPHEDIA, Institut Clinique de la Souris (ICS), Université de Strasbourg, Illkirch, PHENOMIN, France.
Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), CNRS-UMR7104, INSERM U1258, Université de Strasbourg, Illkirch, France.
Mamm Genome. 2025 Jan 13. doi: 10.1007/s00335-024-10099-4.
Genome editing, in particular the CRISPR/Cas9 system, is widely used to generate new animal models. However, the generation of mutations, such as conditional knock-out or knock-in, can remain complex and inefficient, in particular because of the difficulty to deliver the donor DNA (single or double stranded) into the nucleus of fertilized oocytes. The use of recombinant adeno-associated viruses (rAAV) as donor DNA is a rapidly developing approach that promises to improve the efficiency of creation of animal models. In this mini-review, we explore the progress and challenges of using CRISPR/Cas9 in combination with rAAV for precise genome editing. We will summarise the current knowledge of rAAV transduction, data on its use in rodent embryos in combination with CRISPR/Cas9 to easily generate sequence replacements or insertions, the limitations of rAAV and the unexpected events observed to date, and the protocol optimisations already in place to facilitate its use in the generation of animal models.
基因组编辑,尤其是CRISPR/Cas9系统,被广泛用于生成新的动物模型。然而,突变的产生,如条件性敲除或敲入,可能仍然很复杂且效率低下,特别是因为将供体DNA(单链或双链)导入受精卵细胞核存在困难。使用重组腺相关病毒(rAAV)作为供体DNA是一种快速发展的方法,有望提高动物模型创建的效率。在本综述中,我们探讨了将CRISPR/Cas9与rAAV结合用于精确基因组编辑的进展和挑战。我们将总结rAAV转导的现有知识、其与CRISPR/Cas9结合用于啮齿动物胚胎以轻松生成序列替换或插入的数据、rAAV的局限性以及迄今为止观察到的意外事件,以及为便于其在动物模型生成中的应用而已经进行的方案优化。